Rare diseases
Investigational molecules
Locations
200 Continental Drive Suite 401, 19713-4337, United States
Research activity is centred on ulcerative colitis, with a focus on adult patients living with moderately to severely active disease. The sponsor’s clinical interest lies in treatment areas relevant to chronic inflammatory bowel disorders and disease control in the colon and rectum.
Clinical development is directed toward therapeutic options for persistent mucosal inflammation, symptom burden, and disease activity in the gastrointestinal tract.
Mage Biologics Inc. runs clinical trials in conditions such as Colitis ulcerative, among others.
Clinical trials run by this sponsor – those enrolling participants first.
A study to evaluate the safety and effectiveness of MB-001 in adults with moderate to severe ulcerative colitis
PolandIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
